Viex Capital Advisors, LLC Enzo Biochem Inc Transaction History
Viex Capital Advisors, LLC
- $30.9 Million
- Q3 2022
A detailed history of Viex Capital Advisors, LLC transactions in Enzo Biochem Inc stock. As of the latest transaction made, Viex Capital Advisors, LLC holds 1,334,479 shares of ENZ stock, worth $733,963. This represents 9.62% of its overall portfolio holdings.
Number of Shares
1,334,479
Previous 1,536,857
13.17%
Holding current value
$733,963
Previous $3.18 Million
6.44%
% of portfolio
9.62%
Previous 8.4%
Shares
8 transactions
Others Institutions Holding ENZ
# of Institutions
14Shares Held
4.29MCall Options Held
0Put Options Held
0-
Potomac Capital Management, Inc.1.48MShares$814,9583.63% of portfolio
-
Black Rock Inc. New York, NY955KShares$525,2620.0% of portfolio
-
Rbf Capital, LLC San Francisco, CA150KShares$82,5000.0% of portfolio
-
Squarepoint Ops LLC New York, NY141KShares$77,3500.0% of portfolio
-
Lepercq Multi Asset Fund Hamilton, D0123KShares$67,6500.06% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $26.8M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...